Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Thyroid Neoplasms × Lapatinib × Clear all

Sponsor

Conditions

HER2+ Metastatic Breast Cancer (MBC) 1

Interventions

selpercatinib 2 larotrectinib 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 sapanisertib 1 repotrectinib 1 relatlimab 1 pralsetinib 1 pertuzumab 1 pembrolizumab 1 palbociclib 1 osimertinib 1 omipalisib 1 ipatasertib 1 erdafitinib 1 defactinib 1 dabrafenib 1 copanlisib 1 capivasertib 1 cabozantinib 1 binimetinib 1 adavosertib 1 X-Rays 1 Trastuzumab 1 Sunitinib 1 Specimen Handling 1 PF-05280014 1 Ontruzant 1 Ogivri 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡